Heartbeat Health provides virtual-first cardiovascular disease prevention and management, delivering same-day diagnostic reads, televisits, and virtual care programs powered by expert clinicians. Its model uses real-time clinical data and device connectivity to support a range of clinical services. Heartbeat works with payers, provider groups, and at-risk organizations to identify, monitor, and close gaps in care for populations with rising cardiovascular risk. Its clinicians provide diagnostic testing and telehealth across all 50 states to deliver 24/7, on-demand cardiovascular care. Led by CEO and founder Dr. Jeff Wessler, the company plans to enhance its clinical offering and care team and expand access to more customers nationwide. The article does not disclose revenue or other financial metrics. Heartbeat Health operates a data-powered, virtual-first platform for cardiovascular disease prevention and management that combines telemedicine, diagnostic coordination, medication management, lifestyle guidance, and stakeholder engagement. The company emphasizes improving clinical experience and health outcomes while reducing costs through a hybrid provider-and-technology approach. Heartbeat has delivered care to more than 20,000 patients nationwide and counts the American College of Cardiology as a strategic partner. Its leadership includes co-founder and CEO Dr. Jeff Wessler, co-founder and Chief Product Officer Mark Hanson, and co-founder and CTO Nayan Jain. The company is focused on scaling virtual, value-based cardiovascular care for at-risk groups and standardizing care for cardiologists with digital tools and workflows. Heartbeat has raised over $30 million in funding to date and is headquartered in New York City. Heartbeat Health builds a digital-first layer for cardiovascular care that lets patients consult experts via telemedicine who then direct them to appropriate in-person providers. The platform aggregates a patient’s relevant heart data — including from wearable consumer devices like Apple Watch and Fitbit — and tracks which treatments are most effective. CEO and co‑founder Dr. Jeffrey Wessler, a cardiologist who stepped off the academic cardiology path about three years ago, says the company is focused on keeping patients healthy rather than only treating sickness. The company aims to be the software and technology powering coordinated cardiovascular care while ensuring patients are not left behind during the transition. The program works with most commercial insurance and is involved in the care of 10,000 New York‑area patients. The company announced it has raised $8.2 million in Series A funding.

Total raised

$28M

Funding rounds

3

Latest round

Series B

Latest activity

May 2021